Prasol Chemicals IPO Positives and Negatives

Does stock fall in these catagories?: Growth / New Product Growth: The company is showing strong revenue growth 20% CAGR and net profits have doubled, indicating a scaling business model. Capacity Expansion: The company is consistently increasing its installed capacity and maintains high capacity utilization, showing operational momentum. Strong Brand / Relationship: 93% of revenue comes from repeat customers, reflecting deep, long-term relationships and product stickiness in the specialty chemicals market. Debt Management: Unlike peers who load up on debt to expand, Prasol is funding its growth largely through internal accruals and profits. Efficient Asset Base: Most manufacturing facilities are either owned or held on extremely long-term leases 90 years, providing operational stability. Key Risks Discussed: Aggressive IPO Structure: A significant portion of the IPO is an Offer for Sale OFS, meaning money is going to promoters' pockets rather than into the business, which limits future value creation for new investors. Aggressive Valuation: The company is coming in at a P/E ratio of 50, significantly higher than industry peers, leaving little room for listing gains. Working Capital Issues Trade Receivables: A concerning trend where profit is being "locked up" in trade receivables uncollected payments rather than translating into hard cash flow. Macroeconomic Sensitivity: The business is subject to global crude oil price volatility and geopolitical tensions, which impact chemical feedstock costs. Corporate Restructuring: Recent changes in corporate structure make predicting future performance difficult until fresh, post-restructuring quarterly results are released.